by TractManager | Jul 27, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of ForeseeHome (Notal Vision Inc.) for the detection of choroidal neovascularization (CNV) associated with conversion...
by TractManager | Jul 25, 2023 | Emerging Technology Report
AspyreRx (Better Therapeutics Inc.) is a prescription-only digital therapeutic device intended to provide cognitive behavioral therapy to patients 18 years or older with type 2 diabetes (T2D). The device targets behavior to aid in the management of T2D in patients who...
by TractManager | Jul 20, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Dextenza (Ocular Therapeutix Inc.) for the treatment of ocular pain and inflammation after cataract surgery in...
by TractManager | Jul 18, 2023 | Emerging Technology Report
The Phoenix (Evren Technologies Inc.) is a transcutaneous auricular vagus nerve stimulation system and symptom-tracking mobile application under investigation for at-home treatment of posttraumatic stress disorder. If you have a Hayes login, click here to view the...
by TractManager | Jul 17, 2023 | Emerging Technology Report
Lenadogene nolparvovec is an investigational intravitreal adeno-associated virus vector-based gene therapy for the treatment of leber hereditary optic neuropathy.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments